Generation Bio Co.
GBIO
$0.3901
$0.01584.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.99% | -17.48% | -24.87% | -26.41% | 7.34% |
| Total Depreciation and Amortization | -6.31% | -3.86% | -3.03% | -0.34% | 2.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 361.96% | 308.43% | 270.74% | 166.08% | -46.22% |
| Change in Net Operating Assets | -158.71% | -149.07% | -132.91% | 389.84% | 5,018.26% |
| Cash from Operations | -67.91% | -92.55% | -122.45% | 40.05% | 48.52% |
| Capital Expenditure | 67.54% | -88.71% | -101.19% | -26.40% | 15.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4,304.00% | 226.91% | -14.66% | 102.08% | 98.75% |
| Cash from Investing | 1,074.73% | 185.30% | -38.89% | 97.63% | 94.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.81% | -98.75% | -99.04% | -98.90% | 168.33% |
| Repurchase of Common Stock | 67.08% | 54.49% | 55.01% | 37.05% | 2.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 108.38% | 108.38% | -365.52% | -228.00% |
| Cash from Financing | -99.30% | -99.49% | -99.88% | -100.16% | 175.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.35% | -82.95% | -802.68% | 74.52% | 90.56% |